zyrovazet 10&40mg

Zyrovazet is a combination medication used for the management of hyperlipidemia and cardiovascular risk reduction. It combines Rosuvastatin, a potent HMG-CoA reductase inhibitor (statin) that lowers LDL cholesterol and triglycerides, with Ezetimibe, which inhibits the absorption of cholesterol from the small intestine. This dual-action approach provides a more comprehensive lipid-lowering effect than monotherapy, helping patients achieve their target cholesterol levels and reducing the risk of atherosclerosis and associated cardiovascular events.